Test Price
2,800 AED✅ Home Collection Available
ELAC2 Gene Combined Oxidative Phosphorylation Deficiency Type 17 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ELAC2 Gene NGS Test detects precise mutations responsible for Combined Oxidative Phosphorylation Deficiency Type 17, a rare mitochondrial disorder that severely impairs cellular energy production. This advanced next-generation sequencing offers unparalleled accuracy, vital for clinical management, targeted therapy decisions, and informed genetic counseling.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Single Gene) |
|---|---|---|
| Precision / Method | Illumina NovaSeq X Plus – 99.9% diagnostic sensitivity | Sanger sequencing – ~95% analytical sensitivity, limited mutation detection |
| Speed (TAT) | 3–4 Weeks | 4–6 Weeks |
| Regulatory Compliance | DHA/MOHAP Licensed, ISO 9001:2015, UAE PDPL | Variable; often lacks UAE-specific accreditation |
| Price | 2800 AED | 3100–3500 AED |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403) – Consultant Medical Genetics states:
"ELAC2 gene sequencing provides definitive diagnostic information for Combined Oxidative Phosphorylation Deficiency Type 17. Interpretation requires correlation with clinical presentation and family history. Our ISO-accredited NGS platform ensures high sensitivity, but negative results do not exclude all mitochondrial disorders. We are committed to guiding patients through the complex medical and emotional aspects of genetic testing."
Medication Advisory
⚠ Medication Advisory
Do not discontinue or alter any prescribed medication based on test results without consulting your DHA-licensed physician. Test results are intended for diagnostic support, not for immediate treatment changes.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Not for acute metabolic crisis; do not order during active decompensation. Minors require legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability. Patients with known bleeding disorders must inform the phlebotomist before collection.
- ER Red Flags: Seek immediate medical attention if you experience sudden severe lethargy, seizures, respiratory distress, or signs of metabolic acidosis (rapid breathing, confusion).
Patient FAQ & Clinical Guidance
1. What is the ELAC2 Gene Combined Oxidative Phosphorylation Deficiency Type 17 Genetic Test?
ELAC2 genetic testing identifies mutations in the ELAC2 gene causing Combined Oxidative Phosphorylation Deficiency Type 17, a severe mitochondrial disorder that impairs cellular energy production. This NGS panel offers a comprehensive analysis of the entire coding region, ensuring detection of rare pathogenic variants missed by older methods, and provides definitive diagnostic confirmation for appropriate clinical and reproductive planning.
2. Why should I get this test in the UAE?
Choosing our DHA-licensed service guarantees the highest diagnostic accuracy for mitochondrial disorder type 17 using ISO 9001:2015‑certified NGS technology and direct insurance billing verification. You benefit from hospital-grade home collection, rapid 24/7 WhatsApp support, and post-telephonic guidance that ensures clinically actionable results within the UAE healthcare framework.
3. How do I prepare for the sample collection?
No fasting or special preparation is required; you simply schedule a VIP mobile phlebotomy appointment via WhatsApp (+971 54 548 8731) and present a valid Emirates ID and insurance card if applicable. Our nurse will collect a blood sample or accept a pre‑extracted DNA sample, following strict cold‑chain protocols to preserve sample integrity until analysis.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance: This test is conducted in full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds DHA license 1143 and is ISO 9001:2015 certified, ensuring the highest standards of quality and data security.
Clinical & Logistical Metadata
| Test Name | ELAC2 Gene Combined Oxidative Phosphorylation Deficiency Type 17 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood; pre-extracted DNA also accepted |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina NovaSeq X Plus |
| ICD-10-CM Code | E74.810 (Combined oxidative phosphorylation deficiency) |
| LOINC Code | 81304-2 (ELAC2 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians